3//SEC Filing
GV 2019 GP, L.L.C. 3
Accession 0001209191-21-009803
CIK 0001656536other
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 5:27 PM ET
Size
11.6 KB
Accession
0001209191-21-009803
Insider Transaction Report
Form 3
GV 2019 GP, L.L.C.
10% Owner
Holdings
- (indirect: By GV 2019, L.P.)
Series D Preferred Stock
→ Common Stock (819,631 underlying)
GV 2019 GP, L.P.
10% Owner
Holdings
- (indirect: By GV 2019, L.P.)
Series D Preferred Stock
→ Common Stock (819,631 underlying)
GV 2019, L.P.
10% Owner
Holdings
- (indirect: By GV 2019, L.P.)
Series D Preferred Stock
→ Common Stock (819,631 underlying)
Footnotes (2)
- [F1]Each share of Series D Preferred Stock is convertible into shares of the Issuer's common stock, $0.001 par value per share, on a 5.3:1 basis at any time at the holder's election and will automatically convert immediately prior to the closing of the Issuer's initial public offering. The Series D Preferred Stock has no expiration date.
- [F2]The reported securities are held directly by GV 2019, L.P. GV 2019 GP, L.P. (the general partner of GV 2019, L.P.), GV 2019 GP, L.L.C. (the general partner of GV 2019 GP, L.P.), Alphabet Holdings LLC (the sole member of GV 2019 GP, L.L.C.), XXVI Holdings Inc. (the sole member of Alphabet Holdings LLC), and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may each be deemed to have sole power to vote or dispose of these shares. Each of GV 2019 GP, L.P., GV 2019 GP, L.L.C., Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaim beneficial ownership of the shares except to the extent of any pecuniary interest therein.
Issuer
Decibel Therapeutics, Inc.
CIK 0001656536
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001845038
Filing Metadata
- Form type
- 3
- Filed
- Feb 10, 7:00 PM ET
- Accepted
- Feb 11, 5:27 PM ET
- Size
- 11.6 KB